Who we are

We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues.

Learn more
Novartis company structure (Graphic)

What we do

We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments.

Learn more

Strategic priorities

As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.

Photo stories

One boy’s hope to dodge the dire fate of a rare illness

Matteo Almeida, 4, was born with spinal muscular atrophy, a rare genetic disease that leads to progressive muscle weakness.

Read the story

Photo stories

Ghana strives to improve diagnosis and treatment of sickle cell disease

A baby in Ghana at Kumasi General Hospital, which screens newborns for sickle cell disease.

Read the story

Key figures comparison

The interactive key figures comparison lets you compare key values over the past two years.

Novartis key performance indicators (Graphic) View data

Annual reporting suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Read more